Bharat Biotech Debuts World’s First Exclusively Intranasal COVID-19 Vaccine

Does SaNOtize Hold An Edge?

With the world’s first exclusively intranasal COVID-19 vaccine against COVID-19 getting restricted use approval in India, Bharat Biotech/Washington University St. Louis offer an easy-to-use immunization option. But is it too little too late?

Intranasal vaccine
First Exclusively Inhaled COVID-19 Vaccine Approved • Source: Shutterstock

Approval for Bharat Biotech’s intranasal COVID-19 vaccine for restricted use in India is a scientific achievement for the company and its partner Washington University School of Medicine in St. Louis, but the question is whether it’s a tad late.

An announcement of the world’s first exclusively intranasal COVID-19 vaccine being given a nod in India for use in emergency...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip